Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 12/2/2011 11:34:50 AM : Outperform Start Price: $43.92 SLXP Score: +10.75

Increasing sales and margins.

Featured Broker Partners


Advertisement